vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Fastly, Inc. (FSLY). Click either name above to swap in a different company.

COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $173.0M, roughly 1.2× Fastly, Inc.). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -11.9%, a 20.1% gap on every dollar of revenue. On growth, Fastly, Inc. posted the faster year-over-year revenue change (19.8% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $4.1M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 14.3%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

Fastly, Inc. is an American company based in San Francisco, which describes itself as a cloud computing company. Fastly provides content delivery network services, image optimization, and load balancing services. Fastly's cloud security services include denial-of-service attack protection, bot mitigation, and a web application firewall.

COLL vs FSLY — Head-to-Head

Bigger by revenue
COLL
COLL
1.2× larger
COLL
$205.4M
$173.0M
FSLY
Growing faster (revenue YoY)
FSLY
FSLY
+6.8% gap
FSLY
19.8%
12.9%
COLL
Higher net margin
COLL
COLL
20.1% more per $
COLL
8.3%
-11.9%
FSLY
More free cash flow
COLL
COLL
$118.3M more FCF
COLL
$122.4M
$4.1M
FSLY
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
14.3%
FSLY

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
COLL
COLL
FSLY
FSLY
Revenue
$205.4M
$173.0M
Net Profit
$17.0M
$-20.5M
Gross Margin
62.5%
62.5%
Operating Margin
29.6%
23.7%
Net Margin
8.3%
-11.9%
Revenue YoY
12.9%
19.8%
Net Profit YoY
35.3%
47.6%
EPS (diluted)
$0.48
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
FSLY
FSLY
Q1 26
$173.0M
Q4 25
$205.4M
$172.6M
Q3 25
$209.4M
$158.2M
Q2 25
$188.0M
$148.7M
Q1 25
$177.8M
$144.5M
Q4 24
$181.9M
$140.6M
Q3 24
$159.3M
$137.2M
Q2 24
$145.3M
$132.4M
Net Profit
COLL
COLL
FSLY
FSLY
Q1 26
$-20.5M
Q4 25
$17.0M
$-15.5M
Q3 25
$31.5M
$-29.5M
Q2 25
$12.0M
$-37.5M
Q1 25
$2.4M
$-39.1M
Q4 24
$12.5M
$-32.9M
Q3 24
$9.3M
$-38.0M
Q2 24
$19.6M
$-43.7M
Gross Margin
COLL
COLL
FSLY
FSLY
Q1 26
62.5%
Q4 25
62.5%
61.4%
Q3 25
61.7%
58.4%
Q2 25
57.7%
54.5%
Q1 25
54.8%
53.2%
Q4 24
54.0%
53.4%
Q3 24
60.8%
54.5%
Q2 24
62.5%
55.1%
Operating Margin
COLL
COLL
FSLY
FSLY
Q1 26
23.7%
Q4 25
29.6%
-8.7%
Q3 25
29.7%
-18.2%
Q2 25
18.7%
-24.8%
Q1 25
12.2%
-26.4%
Q4 24
20.9%
-24.4%
Q3 24
21.9%
-29.6%
Q2 24
32.7%
-35.3%
Net Margin
COLL
COLL
FSLY
FSLY
Q1 26
-11.9%
Q4 25
8.3%
-9.0%
Q3 25
15.0%
-18.6%
Q2 25
6.4%
-25.2%
Q1 25
1.4%
-27.1%
Q4 24
6.9%
-23.4%
Q3 24
5.9%
-27.7%
Q2 24
13.5%
-33.0%
EPS (diluted)
COLL
COLL
FSLY
FSLY
Q1 26
$-0.13
Q4 25
$0.48
$-0.10
Q3 25
$0.84
$-0.20
Q2 25
$0.34
$-0.26
Q1 25
$0.07
$-0.27
Q4 24
$0.36
$-0.23
Q3 24
$0.27
$-0.27
Q2 24
$0.52
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
FSLY
FSLY
Cash + ST InvestmentsLiquidity on hand
$386.7M
$146.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$301.7M
$977.1M
Total Assets
$1.7B
$1.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
FSLY
FSLY
Q1 26
$146.7M
Q4 25
$386.7M
$361.8M
Q3 25
$285.9M
$342.9M
Q2 25
$222.2M
$321.2M
Q1 25
$197.8M
$307.3M
Q4 24
$162.8M
$295.9M
Q3 24
$120.0M
$308.2M
Q2 24
$271.6M
$311.8M
Stockholders' Equity
COLL
COLL
FSLY
FSLY
Q1 26
$977.1M
Q4 25
$301.7M
$929.6M
Q3 25
$274.8M
$937.0M
Q2 25
$232.2M
$942.6M
Q1 25
$234.4M
$957.0M
Q4 24
$228.8M
$965.3M
Q3 24
$234.3M
$969.5M
Q2 24
$216.6M
$981.2M
Total Assets
COLL
COLL
FSLY
FSLY
Q1 26
$1.5B
Q4 25
$1.7B
$1.5B
Q3 25
$1.6B
$1.5B
Q2 25
$1.6B
$1.5B
Q1 25
$1.6B
$1.4B
Q4 24
$1.7B
$1.5B
Q3 24
$1.6B
$1.5B
Q2 24
$1.1B
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
FSLY
FSLY
Operating Cash FlowLast quarter
$123.0M
$28.9M
Free Cash FlowOCF − Capex
$122.4M
$4.1M
FCF MarginFCF / Revenue
59.6%
2.4%
Capex IntensityCapex / Revenue
0.3%
14.3%
Cash ConversionOCF / Net Profit
7.25×
TTM Free Cash FlowTrailing 4 quarters
$327.6M
$55.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
FSLY
FSLY
Q1 26
$28.9M
Q4 25
$123.0M
$22.4M
Q3 25
$78.4M
$28.9M
Q2 25
$72.4M
$25.8M
Q1 25
$55.4M
$17.3M
Q4 24
$84.6M
$5.2M
Q3 24
$-9.0M
$5.0M
Q2 24
$67.4M
$-4.9M
Free Cash Flow
COLL
COLL
FSLY
FSLY
Q1 26
$4.1M
Q4 25
$122.4M
$12.2M
Q3 25
$78.3M
$22.9M
Q2 25
$72.4M
$15.9M
Q1 25
$54.6M
$14.7M
Q4 24
$84.1M
$251.0K
Q3 24
$-9.2M
$3.0M
Q2 24
$67.1M
$-6.7M
FCF Margin
COLL
COLL
FSLY
FSLY
Q1 26
2.4%
Q4 25
59.6%
7.1%
Q3 25
37.4%
14.5%
Q2 25
38.5%
10.7%
Q1 25
30.7%
10.2%
Q4 24
46.2%
0.2%
Q3 24
-5.8%
2.2%
Q2 24
46.2%
-5.1%
Capex Intensity
COLL
COLL
FSLY
FSLY
Q1 26
14.3%
Q4 25
0.3%
5.9%
Q3 25
0.1%
3.8%
Q2 25
0.0%
6.6%
Q1 25
0.4%
1.8%
Q4 24
0.3%
3.5%
Q3 24
0.2%
1.5%
Q2 24
0.2%
1.3%
Cash Conversion
COLL
COLL
FSLY
FSLY
Q1 26
Q4 25
7.25×
Q3 25
2.49×
Q2 25
6.05×
Q1 25
22.92×
Q4 24
6.75×
Q3 24
-0.96×
Q2 24
3.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

FSLY
FSLY

Network Services$126.2M73%
Security$38.8M22%
Other$8.0M5%

Related Comparisons